Mass. Dx firm raises funds to further develop autism test

03/28/2013 | American City Business Journals

SynapDx has received an undisclosed investment from the Kraft Group, the third round of financing for the firm since December. The Massachusetts-based company will use the money to advance the development of its blood-based test for the early detection of autism spectrum disorder in children.

View Full Article in:

American City Business Journals

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Product Development Manager, Disposable Medical Products
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
Neurovascular Intervention Product Sales Rep, North East
Multiple Locations, SL_Multiple Locations
Vice President of Regulatory Affairs
Pentec Health
Boothwyn, PA
Sr Coordinator Clinical Research (US/TA/00/0073/SL) - 1400000AQX
Santa Clara, CA
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA